{"id":"NCT03697603","sponsor":"Otsuka Pharmaceutical Co., Ltd.","briefTitle":"A Study of Brexpiprazole in Patients With Major Depressive Disorder","officialTitle":"A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial to Assess the Efficacy and Safety of Brexpiprazole as Adjunctive Therapy in Patients With Major Depressive Disorder","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2018-07-30","primaryCompletion":"2022-06-06","completion":"2022-07-04","firstPosted":"2018-10-05","resultsPosted":"2024-08-09","lastUpdate":"2024-08-09"},"enrollment":740,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"Brexpiprazole","otherNames":["REXULTI"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Brexpiprazole 1mg","type":"EXPERIMENTAL"},{"label":"Brexpiprazole 2mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this 14 week, randomized, double-blind, placebo controlled study is to assess the safety and efficacy of brexipiprazole to placebo as adjunctive treatment to an assigned open-label marketed antidepressant therapy (ADT) in patients with Major Depressive Disorder.","primaryOutcome":{"measure":"Mean Changes From Baseline (Week 8 of the Antidepressant Treatment Period [Phase A]) in the MADRS Total Scores at Week 6 of the Double-blind Period (Phase B).","timeFrame":"Baseline (the end of Phase A), at completion of administration (Week 6).","effectByArm":[{"arm":"Brexpiprazole 1 mg","deltaMin":-8.5,"sd":0.47},{"arm":"Brexpiprazole 2 mg","deltaMin":-8.2,"sd":0.47},{"arm":"Placebo","deltaMin":-6.7,"sd":0.47}],"pValues":[{"comp":"OG001 vs OG002","p":"0.0312"},{"comp":"OG000 vs OG002","p":"0.0089"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":250},"commonTop":["Akathisia","Nasopharyngitis","Weight increased","Tremor","Insomnia"]}}